Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Life Sciences|June 2, 2000
Chlorinated dibenzo-p-dioxins and dibenzofurans and the human immune system: 3. Plasma immunoglobulins and cytokines of workers with quantified moderately-increased body burdensR Neubert, L Maskow, G Triebig, et al.The Journal of Biological Chemistry|April 23, 1999
Kinetics and inhibition of recombinant human cystathionine gamma-lyase. Toward the rational control of transsulfurationC Steegborn, T Clausen, P Sondermann, et al.Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|October 20, 2007
[Transarterial chemoperfusion with gemcitabine and mitomycin C in pancreatic carcinoma: results in locally recurrent tumors and advanced tumor stages]T J Vogl, S Zangos, M Heller, et al.Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|September 7, 2007
[Transarterial chemoperfusion of the pelvis--results in symptomatic locally recurrent tumors and lymph node metastases]T J Vogl, S Zangos, K Eichler, et al.Journal of Molecular Biology|July 4, 1997
Crystal structure of the C-terminal tetrad repeat from synexin (annexin VII) of Dictyostelium discoideumS Liemann, I Bringemeier, J Benz, et al.Life Sciences|January 1, 1993
Chlorinated dibenzo-p-dioxins and dibenzofurans and the human immune system. 1. Blood cell receptors in volunteers with moderately increased body burdensR Neubert, L Maskow, J Webb, et al.Nature Structural Biology|August 29, 2001
Crystal structure of the APC10/DOC1 subunit of the human anaphase-promoting complexK S Wendt, H C Vodermaier, U Jacob, et al.The EMBO Journal|October 16, 1999
Crystal structure of gingipain R: an Arg-specific bacterial cysteine proteinase with a caspase-like foldA Eichinger, H G Beisel, U Jacob, et al.Proceedings of the National Academy of Sciences of the United States of America|May 11, 2000
(4-aminomethyl)phenylguanidine derivatives as nonpeptidic highly selective inhibitors of human urokinaseS Sperl, U Jacob, N Arroyo de Prada, et al.Annals of the Rheumatic Diseases|June 15, 2007
Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32)S Werwitzke, D Trick, P Sondermann, et al.Pageof 5